Acknowledgments
INFECTIOUS DISEASES, RECRUITMENT, ALLERGY
This work was supported by the Wellcome Trust through an investigator award (212265/Z/18/Z) and core funding from the Wellcome Centre for Infectious Diseases Research in Africa (203135/Z/16/Z); GMa was supported in part by the National Research Foundation of South Africa (grant number 119078). GMe was supported by the Wellcome Trust (214321/B/18/Z) and the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (grant number 64787). The University of Cape Town Clinical Pharmacology Laboratory was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award number UM1 AI068634, UM1 AI068636, and UM1 AI106701). For the purpose of open access, the author has applied a CC BY public copyright licence to any author-accepted manuscript version arising from this submission. The authors wish to acknowledge the clinical, administrative, and managerial staff of the Wellcome Centre for Infectious Diseases Research in Africa. We thank the clinical and managerial staff at Ubuntu, Michael Mapongwana, Nolungile Community Health Centres, and Khayelitsha District Hospital for assisting with recruitment. We thank the following data and safety monitoring committee members for reviewing interim safety data: Catherine Orrell, Francois Venter, and Beatriz Grinsztejn.